Published in HPB (Oxford) on January 01, 2005
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet (1975) 4.17
Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer (2003) 2.96
Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg (1988) 2.26
Aggressive surgical resection for cholangiocarcinoma. Arch Surg (1995) 1.80
Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg (2002) 1.75
Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg (1993) 1.63
Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc (2002) 1.51
Segment III cholangiojejunostomy for palliation of malignant hilar obstruction. Br J Surg (1994) 1.46
Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc (2002) 1.40
Unresectable hilar cholangiocarcinoma: percutaneous versus operative palliation. Surgery (1994) 1.35
Surgical anatomy of the hepatic hilum with special reference to the caudate lobe. World J Surg (1988) 1.33
Surgical anatomy of the left lateral segment as applied to living-donor and split-liver transplantation: a clinicopathologic study. Ann Surg (2000) 1.13
Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg (1995) 1.09
Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg (1998) 1.07
Hepaticojejunostomy in benign and malignant high bile duct stricture: approaches to the left hepatic ducts. Br J Surg (1984) 1.03
Current concepts in cancer: carcinoma of the biliary tract. N Engl J Med (1979) 1.03
Effective palliation of malignant biliary duct obstruction. Ann Surg (1985) 0.99
Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction. Complications, follow-up and reintervention in 154 patients. Acta Radiol (2003) 0.99
Clinicoanatomical study on the infraportal bile ducts of segment 3. World J Surg (2002) 0.93
Left intrahepatic cholangio-enteric anastomosis (round ligament approach): an effective palliative treatment for hilar cancers. Br J Surg (1987) 0.91
Choice of palliation for malignant hilar biliary obstruction. Am J Surg (1992) 0.89
Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis. World J Surg (2003) 0.80
A single center experience with extrahepatic cholangiocarcinomas. Surgery (2001) 0.79
Intrahepatic cholangiojejunostomy for unresectable malignant biliary tumors with obstructive jaundice. J Hepatobiliary Pancreat Surg (2001) 0.79
Palliative surgery for hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int (2003) 0.79
Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer (2003) 0.79
A modification of segment III intrahepatic cholangiojejunostomy. Am J Surg (2004) 0.77
The anatomical basis for segment III cholangiojejunostomy with analysis of 13 cases. Aust N Z J Surg (1998) 0.77
A technique for the construction of high biliary-enteric anastomoses. Surg Gynecol Obstet (1982) 0.77
Third segment cholangio-jejunostomy in the treatment of unresectable klatskin tumors. Hepatogastroenterology (1996) 0.77
Bile duct injury in the era of laparoscopic cholecystectomy. Br J Surg (2006) 3.36
Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26
Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg (1994) 2.98
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut (2005) 2.82
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Major hepatic resection under total vascular exclusion. Ann Surg (1989) 2.29
Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer (1995) 2.09
Live kidney donor assessment in the UK and Ireland. Br J Surg (1999) 2.02
Humour experience in schizophrenia: relationship with executive dysfunction and psychosocial impairment. Psychol Med (2008) 1.99
Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography. Ann Surg (1995) 1.96
Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients. Br J Cancer (1997) 1.95
Initial experience with a multimodal enhanced recovery programme in patients undergoing liver resection. Br J Surg (2008) 1.93
The administration of an oral carbohydrate-containing fluid prior to major elective upper-gastrointestinal surgery preserves skeletal muscle mass postoperatively--a randomised clinical trial. Clin Nutr (2005) 1.88
Liver resection and transplantation in the management of iatrogenic biliary injury. World J Surg (2007) 1.83
Laparoscopic cholecystectomy. Br J Surg (1991) 1.70
Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg (2006) 1.69
Laser-assisted laparoscopic excision of liver cyst. Br J Surg (1991) 1.68
The use of operative ultrasound in surgery of primary liver tumors. World J Surg (1987) 1.64
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
Systematic review and meta-analysis of survival following extracorporeal liver support. Br J Surg (2011) 1.61
Open cholecystectomy in the laparoscopic era. Br J Surg (2007) 1.56
Renal dysfunction in obstructive jaundice. Br J Surg (1995) 1.53
Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol (2002) 1.53
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
Risk assessment in acute pancreatitis. Br J Surg (2009) 1.47
Segment III cholangiojejunostomy for palliation of malignant hilar obstruction. Br J Surg (1994) 1.46
Value of alpha-foetoprotein for screening of recurrence in hepatocellular carcinoma post resection. Singapore Med J (2012) 1.45
Laparoscopic ultrasonography in the evaluation of the biliary tree during laparoscopic cholecystectomy. Br J Surg (1994) 1.44
What proportion of basic surgical trainees continue in a surgical career? A survey of the factors which are important in influencing career decisions. Surgeon (2009) 1.43
Virtual hepatic resection using three-dimensional reconstruction of helical computed tomography angioportograms. Ann Surg (2001) 1.41
Energy expenditure in acetaminophen-induced fulminant hepatic failure. Crit Care Med (2000) 1.40
Changing management of pyogenic liver abscess. Br J Surg (1996) 1.40
Randomized clinical trial of laxatives and oral nutritional supplements within an enhanced recovery after surgery protocol following liver resection. Br J Surg (2010) 1.39
Haemorrhage following pancreaticoduodenectomy: risk factors and the importance of sentinel bleed. Dig Surg (2006) 1.37
Role of the surgical trainee in upper gastrointestinal resectional surgery. Ann R Coll Surg Engl (1999) 1.34
Segmental liver resection using ultrasound-guided selective portal venous occlusion. Ann Surg (1989) 1.32
Prognostic factors in the palliation of pancreatic cancer. Eur J Surg Oncol (2003) 1.28
Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford) (2007) 1.26
Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy. Surgeon (2003) 1.20
Postchemoembolisation syndrome--tumour necrosis or hepatocyte injury? Br J Cancer (2003) 1.19
Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg (2005) 1.18
Tailoring the management of nonparasitic liver cysts. Ann Surg (1998) 1.17
Systematic review and meta-analysis of continuous local anaesthetic wound infiltration versus epidural analgesia for postoperative pain following abdominal surgery. Br J Surg (2013) 1.13
A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer (1999) 1.11
Interstitial ablative techniques for hepatic tumours. Br J Surg (2003) 1.10
Early specialist repair of biliary injury. Br J Surg (2006) 1.09
Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg (1994) 1.09
Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy. Br J Cancer (2006) 1.09
The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer (2009) 1.09
Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. Br J Cancer (2006) 1.08
Supervised surgical trainees can perform pancreatic resections safely. J R Coll Surg Edinb (1999) 1.07
An audit of the management of patients with acute pancreatitis against national standards of practice. Br J Surg (2007) 1.05
Changing trends in the management of extrahepatic cholangiocarcinoma. Br J Surg (1993) 1.05
Development of quinolone resistance and multiple antibiotic resistance in Salmonella bovismorbificans in a pancreatic abscess. J Antimicrob Chemother (1991) 1.04
Outcome of necrosectomy in acute pancreatitis: the case for continued vigilance. Scand J Gastroenterol (2002) 1.04
Pre-operative high sensitivity C-reactive protein and postoperative outcome in patients undergoing elective orthopaedic surgery. Anaesthesia (2007) 1.03
Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol (1995) 1.03
Needle track seeding of primary and secondary liver carcinoma after percutaneous liver biopsy. HPB Surg (1993) 1.03
Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg (1993) 1.03
Laparoscopic ultrasonography: extending the scope of diagnostic laparoscopy. Br J Surg (1994) 1.02
Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol (2007) 1.02
Cholangiocarcinoma arising after biliary-enteric drainage procedures for benign disease. Gut (2002) 1.01
Hepatic resection for benign non-cystic liver lesions. HPB (Oxford) (2004) 1.01
Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues. Br J Cancer (2006) 1.01
Segmental surgery of the liver. Surg Annu (1988) 1.00
Early experience of laparoscopic ultrasonography in the management of pancreatic carcinoma. Surg Endosc (1993) 1.00
Profuse gastrointestinal haemorrhage due to delayed primary Epstein-Barr virus infection in an immunocompetent adult. Histopathology (2005) 1.00
Does the subspecialty of the surgeon performing primary colonic resection influence the outcome of patients with hepatic metastases referred for resection? Ann Surg (1999) 0.99
Tryptophan catabolites in mesenteric lymph may contribute to pancreatitis-associated organ failure. Br J Surg (2008) 0.98
Case report: prolapse of an ampullary tumour beyond the duodeno-jejunal flexure. Clin Radiol (1993) 0.98
Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study. Br J Cancer (2004) 0.98